Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 19 results for "ranbaxy"

Delhi HC restricts former Ranbaxy promoters from selling assets

The Delhi High Court on Monday ordered former Ranbaxy promoters Malvinder Singh and Shivinder Singh not to part with any unencumbered (charge-free) assets without first approaching the court in a bid to secure funds for a Rs 2,562 crore Singapore arbitration ... Business Standard, 2 weeks ago

28 images for ranbaxy

Money Control, 1 month ago
Financial Express, 2 months ago
Financial Express, 2 months ago
Money Control, 3 months ago, 3 months ago
Uranium Investing News, 4 months ago
Brief, 4 months ago
Yahoo! Finance, 4 months ago
FiercePharma, 4 months ago
Yahoo! Finance, 4 months ago

Daiichi case: HC asks Singh bros to declare value of total stake

In the long drawn court battle between Japanese drugmaker Daiichi Sankyo and the former Ranbaxy promoters Malvinder and Shivinder Singh, the Delhi High Court today ordered the Singh brothers to declare the value of their debt free shareholdings in various ...
 Money Control2 months ago Delhi HC to consider Singh bros-Daiichi case over Ranbaxy on Jan 23  Business Line2 months ago Daiichi Sankyo opposes Fortis Health stake sale, moves Delhi HC  Money Control2 months ago

Trump policies stressful for India pharma cos: Ex-Ranbaxy CEO

Former CEO of Ranbaxy, Brian Tempest, expects more pricing pressure to come in US under Donald Trump administration.
 Money Control1 month ago

Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages

Most analysts noted that the Q3 results were below their estimates, but maintained their buy rating on the stock revising the target price slightly on lower side on hopes of Halol resolution, US specialty play kicking in and normalisation of India business.
 Money Control1 month ago
Money Today

Daiichi-Singh brothers feud: More about arbitration, than about compensation

Delhi High Court is hearing a plea from Japanese drug major Daiichi Sankyo, to prevent the erstwhile promoters of Ranbaxy pharmaceuticals - brothers Malvinder Mohan Singh and Shivinder Mohan Singh - from diluting their stake in Fortis Healthcare. Daiichi's ...
 Money Today2 months ago Daiichi penalty: HC refuses to secure Singh brothers' assets  Business Standard2 months ago Daiichi says Singh brothers' asset declarations false  Business Standard5 days ago Fortis stake sale: Delhi HC to hear Daiichi plea on Jan 23  Money Control2 months ago

Ranbaxy portfolio makes up for 37% of Sun's India sales

Ranbaxy contributes a little lower than Rs 3k cr to the India sales of the merged entity
 Business Standard2 months ago

USFDA to lift import alert on Sun Pharma's Mohali plant

The drug major had inherited the facility as part of its acquisition of Ranbaxy in 2015
 Business Standard1 week ago USFDA to lift import ban on Sun Pharma's Mohali plant  Business Standard1 week ago US FDA ban on Sun Pharma unit lifted after over 3 years  Business Standard1 week ago Sun Pharma says FDA to lift ban on Mohali drug plant  Sify1 week ago

Indian pharma exits the trauma room

India's generic drugmaking industry is getting wheeled out of intensive care. But is it really going home? The US Food and Drug Administration this week lifted the import ban on a factory that Mumbai-based Sun Pharmaceutical Industries inherited as part of ...
 The Financial Chronicle6 days ago

Once upon a time in India Inc...

The list of corporations publishing biographies has lengthened steadily as companies have realised the effectiveness of story telling as a brand building tool. Kanika Datta investigates the rising trend. Illustration: Dominic Xavier/ The dismantling of the licence raj from 1991 onwards provided corporate India with a new-found freedom to grow in any way it chose. Now, well into the 21st century, many corporations and promoters have achieved critical mass. In the process, they ...
 Rediff.com1 month ago

Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

E Kumar Sharma New Delhi Last Updated: January 18, 2017 | 16:43 IST On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its research subsidiary, Daiichi Sankyo India Pharma ...
 Money Today2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less